Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Brain Research

• Publication date

  1991-07-19

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/0006-8993(91)90170-ZPMID 1933318
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions

  2005cited by this paper
• Interaction between recovery from behavioral asymmetries induced by hemivibrissotomy in the rat and the effects of apomorphine and amphetamine

  1990cited by this paper
• Injections of 6-hydroxydopamine in the substantia nigra of the rat brain: morphological and biochemical effects.

  1990cited by this paper
• Interaction between recovery from behavioral asymmetries induced by hemivibrissotomy in the rat and the effects of apomorphine and amphetamine.

  1990cited by this paper
• Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.

  1990cited by this paper
• Compensations after lesions of central dopaminergic neurons: some clinical and basic implications.

  1990cited by this paper
• Preservation of dopamine release in the denervated striatum.

  1989cited by this paper
• Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.

  1988cited by this paper
• Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.

  1988cited by this paper
• Lateralized wall-facing versus turning as measures of behavioral asymmetries and recovery of function after injection of 6-hydroxydopamine into the substantia nigra.

  1988cited by this paper
• Time Course of Adaptations in Dopamine Biosynthesis, Metabolism, and Release Following Nigrostriatal Lesions: Implications for Behavioral Recovery from Brain Injury

  1987cited by this paper
• Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences.

  1987cited by this paper
• Short-term effects of ether, equithesin and droperidol/fentanyl on catecholamine and indolamine metabolism in the brain of the rat.

  1987cited by this paper
• Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage

  1987cited by this paper
• Video image analysis of behavior by microcomputer: categorization of turning and locomotion after 6-OHDA injection into the substantia nigra.

  1987cited by this paper
• Relationship of changes in spontaneous motor activity to spontaneous circling in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.

  1986cited by this paper
• The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra.

  1986cited by this paper
• Effect of forebrain commissurotomy on recovery from unilateral 6-OHDA lesions of the substantia nigra and circling induced by apomorphine.

  1985cited by this paper
• Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs.

  1985cited by this paper
• Brain function: neural adaptations and recovery from injury.

  1984cited by this paper
• Dopamine autoreceptor mediation of the effects of apomorphine on serotonin neurons.

  1984cited by this paper
• Indirect effects of apomorphine on serotoninergic neurons in rats.

  1984cited by this paper
• Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra.

  1984cited by this paper
• The rotational behavior model: asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats.

  1983cited by this paper
• Behavioral and neuronal reorganization after unilateral substantia nigra lesions: evidence for increased interhemispheric nigrostriatal projections.

  1983cited by this paper
• Recovery of function and basal ganglia [14C]2-deoxyglucose uptake after nigrostriatal injury.

  1983cited by this paper
• Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum.

  1983cited by this paper
• Depletion of dopamine in the striatum as an experimental model of Parkinsonism: direct effects and adaptive mechanisms.

  1982cited by this paper
• Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity.

  1982cited by this paper
• Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage.

  1982cited by this paper
• Characterisation of Inhibitory 5‐Hydroxytryptamine Receptors That Modulate Dopamine Release in the Striatum

  1981cited by this paper
• Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior.

  1981cited by this paper
• Supersensitivity in rat caudate nucleus: effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes.

  1980cited by this paper
• Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.

  1980cited by this paper
• Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA.

  1980cited by this paper
• Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.

  1980cited by this paper
• Sensory neglect after lesions of substantia nigra or lateral hypothalamus: differential severity and recovery of function.

  1979cited by this paper
• Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: spontaneous recovery and pharmacological control.

  1979cited by this paper
• Serotonin--dopamine interactions in the nigrostriatal system.

  1979cited by this paper
• Asymmetry of EEG arousal in rats with unilateral 6-hydroxydopamine lesions of substantia nigra: quantification of neglect.

  1978cited by this paper
• Nocturnal rotation in normal rats: correlation with amphetamine-induced rotation and effects of nigrostriatal lesions.

  1978cited by this paper
• High correlations between number of dopamine cells, dopamine levels and motor performance.

  1977cited by this paper
• Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.

  1977cited by this paper
• Sensory inattention produced by 6-hydroxydopamine-induced degeneration of ascending dopamine neurons in the brain.

  1976cited by this paper
• Nigrostriatal bundle damage and the lateral hypothalamic syndrome.

  1974cited by this paper
• Modification du me´tabolisme de la se´rotonine (5-HT) ce´re´brale induite chez le rat par administration de 6-hydroxydopamine

  1973cited by this paper
• [Modification of the metabolism of cerebral serotonin (5-HT) induced in rats by the administration of 6-hydroxydopamine].

  1973cited by this paper
• Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat.

  1973cited by this paper
• Effects of 6-hydroxydopamine on putative transmitter substances in the central nervous system.

  1972cited by this paper
• Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

  1971cited by this paper
• Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

  1971cited by this paper
• EFFECTS OF 6‐HYDROXYDOPAMINE ON CATECHOLAMINE CONTAINING NEURONES IN THE RAT BRAIN

  1970cited by this paper
• Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.

  1970cited by this paper

• Restoration of locomotor function following stimulation of the A13 region in Parkinson’s mouse models

  2025cites this paper
• Therapeutic Viewpoint on Rat Models of Locomotion Abnormalities and Neurobiological Indicators in Parkinson's Disease.

  2023cites this paper
• The effect of dopaminergic neuron transplantation and melatonin co-administration on oxidative stress-induced cell death in Parkinson’s disease

  2022cites this paper
• Lateralization in Hemiparkinsonian Rats Is Affected by either Deep Brain Stimulation or Glutamatergic Neurotransmission in the Inferior Colliculus

  2022influential citation
• ROS dependent neurotoxicity, genotoxicity & histopathological alterations triggered by β-cyfluthrin, a synthetic pyrethroid

  2021cites this paper
• Neuroprotective and Neurorescue Mode of Action of Bacopa monnieri (L.) Wettst in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson’s Disease: An In Silico and In Vivo Study

  2021cites this paper
• Tocotrienols Ameliorate Neurodegeneration and Motor Deficits in the 6-OHDA-Induced Rat Model of Parkinsonism: Behavioural and Immunohistochemistry Analysis

  2021cites this paper
• Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson’s Disease is Mediated by α7-Nicotinic Receptors

  2020cites this paper
• Baicalin attenuated substantia nigra neuronal apoptosis in Parkinson's disease rats via the mTOR/AKT/GSK-3β pathway.

  2019cites this paper
• Designing Functionally Selective Non-Catechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity.

  2019cites this paper
• Neuroprotective and Therapeutic Role of Omega-3 Against Oxidative Stress and Neurotransmitter Disturbances in Rotenone-Induced Mice Model of Parkinson's Disease

  2018cites this paper
• Evidence for cross-hemispheric preconditioning in experimental Parkinson’s disease

  2018cites this paper
• The Role of Human α7-Nicotinic Acetylcholine Receptors in Mediating Neuroprotective Action of Curcumin

  2018cites this paper
• The Effect of Sodium Metabisulphite on Locomotor Activity in the Experimental Model of Parkinson’s Disease: The Role of Cyclooxygenase

  2018cites this paper
• The neuroprotective effects of hydro-alcoholic extract of olive (Olea europaea L.) leaf on rotenone-induced Parkinson’s disease in rat

  2017cites this paper
• Role of ethanolic extract of Bacopa monnieri against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced mice model via inhibition of apoptotic pathways of dopaminergic neurons.

  2017cites this paper
• CART modulates the effects of levodopa in rat model of Parkinson's disease.

  2016cites this paper
• Protective effect of Geraniol on the transgenic Drosophila model of Parkinson's disease.

  2016cites this paper
• Withania somnifera Alleviates Parkinsonian Phenotypes by Inhibiting Apoptotic Pathways in Dopaminergic Neurons

  2014cites this paper
• Geraniol Ameliorates the Motor Behavior and Neurotrophic Factors Inadequacy in MPTP-Induced Mice Model of Parkinson’s Disease

  2013cites this paper
• Neuroprotective Role of Withania somnifera Root Extract in Maneb–Paraquat Induced Mouse Model of Parkinsonism

  2013cites this paper
• Investigations on Alternative Treatment Approaches in the Unilateral 6-OHDA Lesion Rat Model of Parkinson ’ s Disease

  2013cites this paper
• Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol.

  2013cites this paper
• Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat

  2012cites this paper
• Inhaled essential oil from Chamaecyparis obtuse ameliorates the impairments of cognitive function induced by injection of β-amyloid in rats

  2012cites this paper
• The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundle.

  2012cites this paper
• Closing the gap between clinic and cage: sensori-motor and cognitive behavioural testing regimens in neurotoxin-induced animal models of Parkinson's disease.

  2012cites this paper
• S-allyl cysteine mitigates oxidative damage and improves neurologic deficit in a rat model of focal cerebral ischemia.

  2012cites this paper
• Intranasally applied L-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions.

  2012cites this paper
• Alcoholic Extract of Bacopa monniera Linn. Protects Against 6-Hydroxydopamine-Induced Changes in Behavioral and Biochemical Aspects: A Pilot Study

  2012cites this paper
• EFEITOS DA CURCUMINA E DO RESVERATROL EM RATOS COM PARKINSONISMO EXPERIMENTAL INDUZIDO POR 6-HIDROXIDOPAMINA: UM ESTUDO COMPORTAMENTAL E NEUROQUÍMICO

  2012cites this paper
• Nitric Oxide Synthase Inhibitor Improves De Novo and Long-Term l-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats

  2011cites this paper
• Pharmacological challenge and synaptic response – assessing dopaminergic function in the rat striatum with small animal single-photon emission computed tomography (SPECT) and positron emission tomography (PET)

  2011cites this paper
• Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies.

  2011cites this paper
• NEUROPREVENTIVE EFFECT OF SIDA CORDIFOLIA IN PARKINSONIC MICE MODEL

  2011cites this paper
• Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.

  2010cites this paper
• Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinson's disease

  2010cites this paper
• Subtle Cardiovascular Dysfunction in the Unilateral 6-Hydroxydopamine-Lesioned Rat

  2010cites this paper
• Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice

  2010cites this paper
• Time course of deficits in open field behavior after unilateral neostriatal 6-hydroxydopamine lesions

  2009cites this paper
• Effects of intranasally applied dopamine on behavioral asymmetries in rats with unilateral 6-hydroxydopamine lesions of the nigro-striatal tract.

  2009cites this paper
• Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson’s disease

  2007influential citation
• Relation between rotation in the 6‐OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions

  2006cites this paper
• Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease

  2006cites this paper
• Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?

  2006cites this paper
• Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.

  2006cites this paper
• GREEN TEA POLYPHENOL EPIGALLOCATECHIN-3-GALLATE ATTENUATES BEHAVIORAL ABNORMALITY IN HEMI-PARKINSONIAN RAT

  2006cites this paper
• Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.

  2005cites this paper
• Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6‐hydroxydopamine lesioned rat without sensitizing motor behaviours

  2005cites this paper
• Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats.

  2005cites this paper
• ESTUDO DE MECANISMOS DOPAMINÉRGICOS, NICOTÍNICOS E ADENOSINÉRGICOS EM MODELOS DE PARKINSONISMO INDUZIDO POR 6-HIDROXIDOPAMINA E MPTP EM RATOS

  2004cites this paper
• Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence.

  2004cites this paper
• Is the unilateral lesion of the left substantia nigra pars compacta sufficient to induce working memory impairment in rats?

  2004cites this paper
• Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease.

  2004cites this paper
• Dose‐dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences

  2003cites this paper
• Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat.

  2003cites this paper
• Protective effect of adenosine in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences.

  2003cites this paper
• D2‐mediated modulation of N‐type calcium currents in rat globus pallidus neurons following dopamine denervation

  2002cites this paper
• Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance.

  2002cites this paper
• Vitamin E and Neurodegenerative Disorders Associated with Oxidative Stress

  2002cites this paper
• [Microdialysis cerebral. Main application of this technique].

  2001cites this paper
• Chronic levodopa therapy does not improve skilled reach accuracy or reach range on a pasta matrix reaching task in 6‐OHDA dopamine‐depleted (hemi‐Parkinson analogue) rats

  2001cites this paper
• Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence.

  2001cites this paper
• Early behavioral changes after nigro-striatal system damage can serve as predictors of striatal dopamine depletion.

  1999cites this paper
• Behavioral asymmetries and neurochemical changes after unilateral lesions of tuberomammillary nucleus or substantia nigra

  1998cites this paper
• Priming with L-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopamine-lesioned rats after challenge with dopamine D1-receptor agonist.

  1998cites this paper
• Effects of intraaccumbens microinjections of quinopirole on head turning and circling movement in the rat.

  1998cites this paper
• [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].

  1998cites this paper
• Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions.

  1997cites this paper
• Infusions of Tyrosine Hydroxylase Antisense Oligodeoxynucleotide into Substantia Nigra of the Rat: Effects on Tyrosine Hydroxylase mRNA and Protein Content, Striatal Dopamine Release and Behaviour

  1997cites this paper
• Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion.

  1997cites this paper
• Automated Video-Image Analysis of Behavioral Asymmetries

  1996cites this paper
• The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments.

  1996cites this paper
• Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression

  1996cites this paper
• Circling behaviour induced by apomorphine after lesions of the habenula

  1996cites this paper
• Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae.

  1996cites this paper
• Neurokinin-3 receptors modulate dopamine cell function and alter the effects of 6-hydroxydopamine.

  1995cites this paper
• Stimulation of D1- or D2-receptors in drug-naive rats with different degrees of unilateral nigro-striatal dopamine lesions

  1995cites this paper
• Modifications of head turning and circling movement following sulpiride microinjections into nucleus accumbens in the rat.

  1995cites this paper
• L-DOPA and psychosis: evidence for L-DOPA-induced increases in prefrontal cortex dopamine and in serum corticosterone.

  1995cites this paper
• 6-Hydroxydopamine Lesions of Nigrostriatal Neurons as an Animal Model of Parkinson’s Disease

  1994cites this paper
• Differentiation of motor inactivation from movement asymmetry effects in an animal model of hemi‐parkinsonism

  1994cites this paper
• Asymmetrical orientation to edges of an openfield: modulation by striatal dopamine and relationship to motor asymmetries in the rat.

  1994cites this paper
• Behavioral asymmetries and recovery in rats with different degrees of unilateral striatal dopamine depletion.

  1994cites this paper
• 'Priming' enhances the relationship of striatal L-dopa concentration to behavior.

  1994cites this paper
• Accumbens microinjection of LY 171555 and sulpiride: effects on circling behaviour, in the rat.

  1994cites this paper
• L-dopa induced increases in brain uric acid in an animal model of Parkinson's disease: a relationship to behavioral activation.

  1994cites this paper
• l‐3,4‐Dihydroxyphenylalanine‐Induced Dopamine Release in the Striatum of Intact and 6‐Hydroxydopamine‐Treated Rats: Differential Effects of Monoamine Oxidase A and B Inhibitors

  1994cites this paper
• Behavioral indices of moderate nigro‐striatal 6‐hydroxydopamine lesion: A preclinical Parkinson's model

  1993cites this paper
• Behavioral analysis of asymmetries induced by unilateral 6-OHDA injections into the substantia nigra.

  1993cites this paper
• A video image analyzing system for open-field behavior in the rat focusing on behavioral asymmetries.

  1993cites this paper
• Recovery from unilateral 6-hydroxydopamine lesion of substantia nigra promoted by the neurotachykinin substance P 1-11.

  1992cites this paper
• Opponent-process theory and drug conditioning: an assessment for conditioned stimulant-induced movement.

  1992cites this paper
• Factors in amphetamine-induced contralateral rotation in the unilateral 6-OHDA lesion rat model during the first-week postoperative: implications for neuropathology and neural grafting.

  1992cites this paper